Zoledronic Injection IP
Zoledronic Injection IP

Zoledronic Injection IP

Price 999 INR/ Vial

MOQ : 10 Vials

Zoledronic Injection IP Specification

  • Salt Composition
  • Zoledronic Acid 5mg/100ml
  • Indication
  • Osteoporosis, Hypercalcemia of malignancy, Pagets disease
  • Dosage Form
  • Injection
  • Feature
  • Single dose vial, ready-to-use solution
  • Ingredients
  • Zoledronic Acid, Excipient, Water for Injection
  • Application
  • Intravenous use
  • Ph Level
  • Approximately 6.0-7.0
  • Physical Color/Texture
  • Clear, colorless solution
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store below 30C, protect from light
  • Shelf Life
  • 24 months
  • Storage Precaution
  • Do not freeze
  • Administration Route
  • Intravenous infusion
  • Strength
  • 5mg Zoledronic Acid per vial
  • Molecular Formula
  • C5H10N2O7P2
  • Marketed By
  • As mentioned on packaging
  • Pack Size
  • 100ml vial
  • Barcode/Batch No.
  • As printed on labels
  • Packaging Type
  • Glass vial with aluminum seal
  • Intended Patient
  • Adults
  • Prescription Status
  • Prescription only
  • Contraindications
  • Known hypersensitivity to Zoledronic Acid, severe renal impairment
 
 

About Zoledronic Injection IP



Utilise Offer on Zoledronic Injection IP, the valuable new release in osteoporosis therapy garnering favorable reviews among healthcare professionals. With a sterling composition of Zoledronic Acid 5mg/100ml, this best single-dose vial is intended for adult patients administered via intravenous infusion. The clear, odorless solution comes in a secure glass vial with an aluminum seal, ensuring high market value for distributors, exporters, suppliers, and traders in India. Zoledronic Injection IP effectively treats hypercalcemia of malignancy and Paget's disease, providing dependable results for prescription-only requirements. Strict storage guidelines enhance shelf life up to 24 months.

Zoledronic Injection IP: Precision and Reliability

Type of usage for Zoledronic Injection IP is strictly intravenous, employing hospital-grade administration for optimal efficacy. Its features include a ready-to-use, single-dose formulation in a sterile glass vial with an aluminum seal. The major advantage lies in its stability, clear solution, and straightforward application, supporting quick clinical workflow. This system ensures precise dosing, reducing errors and offering strong reliability for treating osteoporosis, Paget's disease, and hypercalcemia of malignancy in adult patients.


Shipment Value: Packaging and FOB Details

Zoledronic Injection IP is shipped from India, utilizing reliable transport services to maintain market value and product integrity. Each vial is expertly packaged in glass, secured with an aluminum seal, and labeled with batch and barcode information for traceability. Shipment details include careful handling and protection against light and temperature extremes. Sample policy is available on request, promoting easier market access and streamlined testing for distributors and exporters seeking favorable shipment terms.


FAQ's of Zoledronic Injection IP:


Q: How should Zoledronic Injection IP be administered for best results?

A: Zoledronic Injection IP is optimally administered via intravenous infusion in a clinical setting, ensuring accurate dosing and effective treatment outcomes.

Q: What is the recommended storage condition for Zoledronic Injection IP?

A: Store the injection below 30C, protect it from light, and avoid freezing to maintain its stability and 24-month shelf life.

Q: When is Zoledronic Injection IP contraindicated for use?

A: Zoledronic Injection IP should not be used in patients with known hypersensitivity to Zoledronic Acid or those suffering from severe renal impairment.

Q: Where can Zoledronic Injection IP be sourced from in India?

A: It is available through licensed distributors, exporters, suppliers, and traders. Additional marketing and batch details can be found on product packaging and labels.

Q: What are the main indications for using Zoledronic Injection IP?

A: It is indicated for the treatment of osteoporosis in adults, hypercalcemia of malignancy, and Paget's disease, providing significant clinical benefits through intravenous administration.

Q: How does the packaging of Zoledronic Injection IP ensure product integrity?

A: Packaged in a glass vial with an aluminum seal, each unit offers robust protection and clear labeling for safe identification and handling during transport and storage.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injectables Category

100 Mg Pemetrexed For Injection

100 Mg Pemetrexed For Injection

Price 800 INR / Box

Minimum Order Quantity : 1 Box

Application : Other, Antineoplastic (Chemotherapy)

Dosage Form : Lyophilized Powder for Injection

Feature : Other, Ready for reconstitution

Indication : Malignant pleural mesothelioma, Nonsmall cell lung cancer

60 Mg Apalutamide Tablets

60 Mg Apalutamide Tablets

Price 30000 INR / Bottle

Minimum Order Quantity : 1 Bottle

Application : Other, Oral administration for prostate cancer therapy

Dosage Form : Tablet

Feature : Other, Selective androgen receptor inhibitor; convenient oral dosage

Indication : Treatment of nonmetastatic castrationresistant prostate cancer (nmCRPC)

2.5 Mg Fondaparinux Sodium Injection

2.5 Mg Fondaparinux Sodium Injection

Price 400 INR / Piece

Minimum Order Quantity : 1 Piece

Application : Other, Hospital, Clinical, Prescribed under medical supervision

Dosage Form : Injection (Prefilled Syringe)

Feature : Other, Ready to use, singleuse prefilled syringe

Indication : Prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

100 Mg Bosutinib Tablets

100 Mg Bosutinib Tablets

Price 5000 INR / Box

Minimum Order Quantity : 10 Boxes

Application : Other, Oncology

Dosage Form : Filmcoated Tablet

Feature : Other, Prescription medicine for targeted cancer therapy

Indication : Treatment of chronic myeloid leukemia (CML)



Back to top